Evalute The Curative Effect Of Minimally Invasive Treatment And Small Bone Window Craniotomy Of Hypertensive Cerebral Hemorrhage

Objective:To compare the curative effect of minimally invasive treatment of hematoma aspiration combined urokinase therapy and the small bone window hematoma evacuation for hypertensive cerebral hemorrhage merits.Methods:The selected patients which were permitted by their families were randomly divided into two groups based on the screening principles. One group using the YL-1 hematoma puncture needle for minimally invasive treatment of hypertensive cerebral hemorrhage, after the operation administrated 2 ten- thousand units urokinase into hematoma cavity daily. the other taking hematoma evacuation with a small bone window in order to remove the hematoma. Results:There was no significant difference in the NIHSS score and 3-month outcome on the GOS score, but minimally invasive with less trauma, shorter hospital stay, fewer complications and the same treatment effect compared with the craniotomy group. Conclusion:If there is no significant difference in the final prognosis of the case, try to select the shorter length of stay, less invasive, easy to carry out the treatment. Selecting the minimally invasive treatment in the supratentorial intracerebral hematoma of 30 60ml volume patients, is better than the treatment of small bone window craniotomy. To the larger amount of hematoma volume with life disorders patients, craniotomy can be lifted intracranial hypertension as soon as possible and controlled the rate of progression of the disease effectively if the hospital conditions were permitted.